EP3327127

MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Application Number
EP17199166A
Filing Date
Dec 12, 2013
Status
Granted And Under Opposition
Feb 19, 2021
Grant Date
Mar 24, 2021
External Links
Slate, Register

Biblio Summary

The patent EP3327127B1 was granted on Mar 24, 2021 by Massachusetts Institute Of Technology The patent is currently Granted And Under Opposition.

The table below shows 3 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

PATENT BOUTIQUE LLPJun 29, 2021ADMISSIBLE
GRUND, DR., MARTINJun 11, 2021ADMISSIBLE
CRISPR THERAPEUTICS AGApr 7, 2021ADMISSIBLE

The table below shows the patents of Massachusetts Institute Of Technology that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3294873Targeting Bcl11A Enhancer Functional Regions For Fetal Hemoglobin ReinductionSep 18, 20241
EP3604532Novel Crispr Enzymes And SystemsMay 1, 20241
EP3237615Crispr Having Or Associated With Destabilization DomainsJul 26, 20232